The ridge regression coefficients (BGN = −0.04476041; COMP = −0.03469480; COL5A2 = −0.09465680; SPARC = 0.39870514) of the selected genes were used to develop a novel prognostic biomarker (“risk”) for predicting the individual risk of GC progression. This evidence concerns the gene SPARC and gastric cancer.